IOL iterations abound, but shape-changing accommodating lens remains end goal

Healio | OSN focuses on a topic dear to my heart, premium IOLs.
In 2013, Malvina B. Eydelman, MD, director of the FDA’s Division of Ophthalmic and Ear, Nose and Throat Devices, chaired an expert panel titled “Developing Novel Endpoints for Premium Intraocular Lenses Workshop.” The result of this workshop was the placement of all IOLs into five main categories.
In the first category were spherical and aspheric monofocal (M) IOLs that demonstrated less than 0.5 D depth of focus. In multiple well-controlled clinical trials, best corrected, a M IOL (Read more...)